Chronic Idiopathic Thrombocytopenic Purpura clinical trials

Explore recruiting chronic idiopathic thrombocytopenic purpura clinical trials.

Recruiting chronic idiopathic thrombocytopenic purpura studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Idiopathic Thrombocytopenic Purpura trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ARGX-113-2409: A Multicenter, Randomized, Double-blinded, Parallel-Arm, Placebo- Controlled, Pharmacokinetic and Pharmacodynamic Study Followed by an Open-Label Arm to Evaluate Efgartigimod IV in Pediatric Participants from 12 Years to Less Than 18 Years of Age with Chronic ITP

Lithuania, Romania, Hungary, France, Italy, Spain +2 more

Phase II and Phase III (Integrated) EU CTIS Study details

Chronic Idiopathic Thrombocytopenic Purpura trials by city

Chronic Idiopathic Thrombocytopenic Purpura in Toronto Chronic Idiopathic Thrombocytopenic Purpura in Vancouver Chronic Idiopathic Thrombocytopenic Purpura in Montreal Chronic Idiopathic Thrombocytopenic Purpura in Calgary Chronic Idiopathic Thrombocytopenic Purpura in Edmonton Chronic Idiopathic Thrombocytopenic Purpura in Ottawa Chronic Idiopathic Thrombocytopenic Purpura in Winnipeg Chronic Idiopathic Thrombocytopenic Purpura in Quebec City Chronic Idiopathic Thrombocytopenic Purpura in Hamilton Chronic Idiopathic Thrombocytopenic Purpura in Kitchener Chronic Idiopathic Thrombocytopenic Purpura in London Chronic Idiopathic Thrombocytopenic Purpura in Halifax Chronic Idiopathic Thrombocytopenic Purpura in New York Chronic Idiopathic Thrombocytopenic Purpura in Los Angeles Chronic Idiopathic Thrombocytopenic Purpura in Chicago Chronic Idiopathic Thrombocytopenic Purpura in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease